Vitamin D deficiency predicts decline in kidney allograft function: A prospective cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 2, 2014, Pages 527-535

  Obi, Yoshitsugu ^a   Hamano, Takayuki ^a   Ichimaru, Naotsugu ^a   Tomida, Kodo ^b   Matsui, Isao ^a   Fujii, Naohiko ^c   Okumi, Masayoshi ^a   Kaimori, Jun Ya ^a   Yazawa, Koji ^a   Kokado, Yukito ^d   Nonomura, Norio ^a   Rakugi, Hiromi ^a   Takahara, Shiro ^a   Isaka, Yoshitaka ^a   Tsubakihara, Yoshiharu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c Hyogo Prefectural Nishinomiya Hospital   (Japan)

^d Takahashi Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84893749733     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2421     Document Type: Article

References (50)

1. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388-399.
2. Bartel G, Schwaiger E, Bohmig GA. Prevention and treatment of alloantibody-mediated kidney transplant rejection. Transpl Int. 2011;24:1142-1155.
3. Wu O, Levy A, Briggs A, Lewis G, Jardine A. Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation. 2009;87:1330.
4. Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitaminDin transplant recipients. Transplantation. 2010; 89:131-137.
5. Redaelli CA, WagnerM,Gunter-Duwe D, et al. 1-,25-Dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int. 2002; 61:288-296.
6. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1-,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001;167:1945-1953.
7. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941-955.
8. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol. 2013;40:265-272.
9. Soilu-Hanninen M, Aivo J, Lindstrom BM, et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon -1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012;83:565-571.
10. Bienaime F, Girard D, Anglicheau D, et al. Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol. 2013;24: 831-841.
11. Bitetto D, Fabris C, Falleti E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2010;30:417-444.
12. Lowery EM, Bemiss B, Cascino T, et al. Low vitamin D levels are associated with increased rejection and infections after lung transplantation. J Heart Lung Transplant. 2012;31:700-707.
13. Sasaki S. Dietary reference intakes (DRIs) in Japan. Asia Pac J Clin Nutr. 2008;17:420-444.
14. Nanri A, Foo LH, Nakamura K, et al. Serum 25-hydroxyvitamin d concentrations and season-specific correlates in Japanese adults. J Epidemiol. 2011;21:346-353.
15. Tomida K, Hamano T, Ichimaru N, et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone. 2012;51:729-736.
16. Wagner D, Hanwell HE, Vieth R.Anevaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009;42:1549-1556.
17. Lewis J, Greene T, Appel L, et al.Acomparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol. 2004;15:3175-3183.
18. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41-50.
19. Levey AS, Stevens LA, Schmid CH, et al.Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
20. Stevens LA, Schmid CH, Zhang YL, et al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010;25:449-457.
21. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32-38.
22. Amemiya H. 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative Transplant Study Group for NKT-01. Artif Organs. 1996;20:832-835.
23. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2011.
24. Japan Meteorological Agency. Mean daily cumulative dose of ultraviolet-B radiation by month. http://www.data.kishou.go.jp/obsenv/uvhp/uvb-monthave-Tsu. html. Accessed January 12, 2013.
25. The Japanese Society for Clinical Renal Transplantation TJSft. Annual Progress Report from the Japanese Renal Transplant Registry, 2010. Part III: results from 2009 Recipient Follow-up Survey. Isyoku. 2010;45:608-620.
26. KDIGOclinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-S130.
27. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503-1510.
28. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165: 710-718.
29. Rosenbaum PR. Optimal matching for observational studies. J Am Statist Assoc. 1989;84:1024.
30. Duncan JL, Harrild KA, Iversen L, Lee AJ, Godden DJ. Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study. BMJ. 2012;344:e2958.
31. Selvin S. Statistical Analysis of Epidemiologic Data. Oxford, United Kingdom: Oxford University Press; 2004.
32. Tanaka H, Hamano T, Fujii N, et al. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009;45: 949-955.
33. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch InternMed. 2008; 168:1340-1349.
34. Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011;93:1006-1011.
35. Ewers B, Gasbjerg A, Moelgaard C, Frederiksen AM, Marckmann P. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr. 2008;87:431-437.
36. Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD. Vitamin D status in renal transplant recipients. Am J Transplant. 2007;7:2546-2552.
37. Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab. 2006;91:526-529.
38. Lentine KL, Gheorghian A, Axelrod D, Kalsekar A, L'Italien G, Schnitzler MA. The implications of acute rejection for allograft survival in contemporary US kidney transplantation. Transplantation. 2012;94:369-376.
39. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-Term renal allograft survival in the United States: a critical reappraisal.AmJ Transplant. 2011;11:450-462.
40. National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
41. Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370-1378.
42. Nakano C, Hamano T, Fujii N, et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol. 2012;7:810-819.
43. Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, et al. Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol. 2012;23:1190-1197.
44. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease.AmJ Nephrol. 2009;30:64-72.
45. Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34:680-687.
46. Saenger AK, Laha TJ, Bremner DE, Sadrzadeh SM. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-Tandem mass spectrometry and examination of reference intervals for diagnosis of vitaminDdeficiency.AmJ Clin Pathol. 2006;125:914-920.
47. Tsugawa N, Suhara Y, Kamao M, Okano T. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-Tandem mass spectrometry. Anal Chem. 2005;77: 3001-3007.
48. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
49. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int. 2010;78:134-139.
50. Stein EM, Shane E. VitaminDin organ transplantation. Osteoporos Int. 2011;22:2107-2118.